MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC

Position in GILD — Gilead Sciences, Inc.

CIK 1015877 ORLEANS, MA

Back to GILD Full portfolio

Position in GILD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$272,641

-$28,119 QoQ

Shares Held

2,158

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.33%

of 13F equity value

Holder Rank

#1,722

of 2,266 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

MCINTYRE FREEDMAN & FLYNN INVESTMENT ADVISERS INC holds $3,410,790 across 4 Drug Manufacturers - General names. GILD ranks #4 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	8,899	$2,260,079
2	AMGN	Amgen Inc	1,557	$563,820
3	LLY	ELI LILLY & Co	262	$314,250
4	GILD	Gilead Sciences, Inc. This page	2,158	$272,641

All Filings in GILD

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$272,641	2,158	0.0%	Shares	Sole	2026-08-12
2026-03-31	$300,760	2,158	0.0%	Shares	Sole	2026-05-13
2025-12-31	$264,872	2,158	0.0%	Shares	Sole	2026-02-12
2025-09-30	$239,538	2,158	—	Shares	Sole	2025-11-13
No filing history on record for this holder in this stock.